
Amyloid‐β in mitochondrial disease: mutation in a human metallopeptidase links amyloidotic neurodegeneration with mitochondrial processing
Author(s) -
Boczonadi Veronika,
Horvath Rita
Publication year - 2016
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.201506050
Subject(s) - neurodegeneration , amyloid (mycology) , mitochondrion , mutation , mitochondrial dna , mitochondrial disease , biology , disease , microbiology and biotechnology , pathology , medicine , genetics , gene
There is increasing evidence that common molecular pathways in neurons are closely linked with mitochondrial function and that mitochondrial dysfunction is connected to various forms of neurodegenerative diseases. For instance, mitochondria are involved in amyloid‐β (Aβ) deposition in Alzheimer's disease, although the exact molecular pathways remain largely unknown. Brunetti et al ([Brunetti D, 2015]) in this issue of EMBO Molecular Medicine provide a novel link between Aβ accumulation and mitochondria. A pathogenic mutation in a Norwegian family in the mitochondrial metallopeptidase PITRM 1 is found to underlie a novel mitochondrial neurodegenerative phenotype associated with Aβ accumulation.